Acitretin Therapy May Help Reduce Nail Psoriasis Symptoms
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Acitretin Therapy May Help Reduce Nail Psoriasis Symptoms

CHICAGO -- March 16, 2009 -- Low-dose acitretin therapy appears to reduce nail psoriasis symptoms, according to a study published in the March issue of Archives of Dermatology.

Antonella Tosti, MD, University of Bologna, Bologna, Italy, and colleagues evaluated the effectiveness of acitretin 0.2 mg to 0.3 mg per kg per day for 6 months on the nails of 36 patients (27 male, mean age 41 years) who had psoriasis involving only the nails.

Researchers used the Nail Psoriasis Severity Index (NAPSI) to grade the severity of the condition. Higher NAPSI scores indicated more severely affected nails. Patients were followed up for at least 6 months after treatment.

"The mean percentages of reduction of the NAPSI score and modified NAPSI score were 41% and 50%" the authors wrote. "Clinical evaluation at 6 months showed complete or almost complete clearing of the nail lesions in 9 patients (25%), moderate improvement in 9 (25%), mild improvement in 12 (33%) and no improvement in 6 (11%)."

"Only 1 of the 36 patients experienced adverse effects on the nail during treatment," the authors noted. All participants whose condition improved did not return to pre-treatment conditions.

"Although more studies are required to thoroughly assess the effectiveness in larger controlled subject populations, our observations suggest that low-dose systemic acitretin should be considered in the therapeutic armamentarium in the treatment of nail psoriasis," the authors concluded.

SOURCE: Archives of Dermatology

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities